共 26 条
[1]
[8]
Phase II study of ASA404 (vadimezan; 5;6-dimethylxanthenone-4-acetic acid/DMXAA) 1800<ce:hsp sp="0.25"/>mg/m 2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.[J].Mark J. McKeage;Martin Reck;Michael B. Jameson;Mark A. Rosenthal;David Gibbs;Paul N. Mainwaring;Lutz Freitag;Richard Sullivan;Joachim Von Pawel.Lung Cancer.2009, 2

